Neogen Beheer
Beheer criteriumcontroles 3/4
De CEO Neogen is John Adent, benoemd in Jul2017, heeft een ambtstermijn van 7.33 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 7.22M, bestaande uit 11.1% salaris en 88.9% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.11% van de aandelen van het bedrijf, ter waarde $ 3.55M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.8 jaar en 6.8 jaar.
Belangrijke informatie
John Adent
Algemeen directeur
US$7.2m
Totale compensatie
| Percentage CEO-salaris | 11.1% |
| Dienstverband CEO | 7.3yrs |
| Eigendom CEO | 0.1% |
| Management gemiddelde ambtstermijn | 2.8yrs |
| Gemiddelde ambtstermijn bestuur | 6.8yrs |
Recente managementupdates
Recent updates
Neogen Stock: Expect Volatility To Continue Amid Weak Growth
Oct 11Risks To Shareholder Returns Are Elevated At These Prices For Neogen Corporation (NASDAQ:NEOG)
Aug 28
We Think Neogen (NASDAQ:NEOG) Is Taking Some Risk With Its Debt
Jul 31Neogen Corporation: Challenges Remain
Jun 26There's Reason For Concern Over Neogen Corporation's (NASDAQ:NEOG) Price
May 21Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust
Apr 15Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
Apr 12Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt
Mar 29Neogen: All About Execution From Here On
Mar 26Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are
Jan 17Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Jan 12Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected
Jan 09Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly
Dec 06Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Jul 12Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?
Jun 20Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Mar 25Neogen introduces ready-to-use disinfectant Companion RTU for veterinary use
Oct 10Neogen GAAP EPS of $0.05, revenue of $132.35M
Sep 27Neogen drops 9% as merger with 3M’s food safety business closes
Sep 01Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher
Aug 21Neogen: Cut In Half, Still Some Questions
Aug 12There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings
Aug 04Neogen: Thesis Unchanged After Q4 And Full-Year Earnings
Aug 01Neogen FQ4 2022 Earnings Preview
Jul 25Zoetis, IDEXX named as buys in animal health space by Piper Sandler
Jul 13Neogen announces pricing of $350M senior notes offering
Jul 07Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Aug 31 2024 | n/a | n/a | -US$24m |
| May 31 2024 | US$7m | US$803k | -US$9m |
| Feb 29 2024 | n/a | n/a | US$2m |
| Nov 30 2023 | n/a | n/a | US$12m |
| Aug 31 2023 | n/a | n/a | -US$27m |
| May 31 2023 | US$5m | US$671k | -US$23m |
| Feb 28 2023 | n/a | n/a | -US$13m |
| Nov 30 2022 | n/a | n/a | -US$16m |
| Aug 31 2022 | n/a | n/a | US$36m |
| May 31 2022 | US$4m | US$478k | US$48m |
| Feb 28 2022 | n/a | n/a | US$49m |
| Nov 30 2021 | n/a | n/a | US$57m |
| Aug 31 2021 | n/a | n/a | US$62m |
| May 31 2021 | US$3m | US$459k | US$61m |
| Feb 28 2021 | n/a | n/a | US$61m |
| Nov 30 2020 | n/a | n/a | US$60m |
| Aug 31 2020 | n/a | n/a | US$61m |
| May 31 2020 | US$2m | US$389k | US$59m |
| Feb 29 2020 | n/a | n/a | US$59m |
| Nov 30 2019 | n/a | n/a | US$60m |
| Aug 31 2019 | n/a | n/a | US$60m |
| May 31 2019 | US$2m | US$450k | US$60m |
| Feb 28 2019 | n/a | n/a | US$62m |
| Nov 30 2018 | n/a | n/a | US$65m |
| Aug 31 2018 | n/a | n/a | US$66m |
| May 31 2018 | US$2m | US$394k | US$63m |
Compensatie versus markt: De totale vergoeding ($USD 7.22M ) John } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 6.65M ).
Compensatie versus inkomsten: De vergoeding van John is gestegen terwijl het bedrijf verliesgevend is.
CEO
John Adent (56 yo)
7.3yrs
Tenure
US$7,221,352
Compensatie
Mr. John Edward Adent has been Chief Executive Officer at Neogen Corporation since July 17, 2017 and has been its President since September 22, 2017. He has been Director of Neogen Corporation since 2018....
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 7.3yrs | US$7.22m | 0.11% $ 3.6m | |
| Chief Financial Officer | 1.8yrs | US$4.81m | 0.018% $ 564.5k | |
| COO & VP | 2.6yrs | US$2.50m | 0.033% $ 1.0m | |
| Chief Legal & Compliance Officer and Corporate Secretary | 3.7yrs | US$1.66m | 0.011% $ 343.6k | |
| VP, Corporate Controller & Chief Accounting Officer | less than a year | geen gegevens | geen gegevens | |
| VP & Chief Scientific Officer | 2.8yrs | geen gegevens | geen gegevens | |
| Administrative Manager | no data | geen gegevens | geen gegevens | |
| Head of Investor Relations | no data | geen gegevens | geen gegevens | |
| VP & Chief Human Resources Officer | 7.8yrs | geen gegevens | geen gegevens |
2.8yrs
Gemiddelde duur
54yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van NEOG wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 6.8yrs | US$7.22m | 0.11% $ 3.6m | |
| Independent Director | 10.1yrs | US$242.50k | 0.0059% $ 184.6k | |
| Independent Director | 13.5yrs | US$247.50k | 0.014% $ 450.6k | |
| Independent Director | 2.2yrs | US$237.50k | 0.0027% $ 85.4k | |
| Independent Chairman | 8.1yrs | US$270.00k | 0.012% $ 368.0k | |
| Independent Director | 4.1yrs | US$235.00k | 0.0016% $ 49.1k | |
| Independent Director | 8.1yrs | US$246.25k | 0.013% $ 396.8k | |
| Independent Director | 4.1yrs | US$238.75k | 0.0034% $ 108.0k | |
| Independent Director | 2.2yrs | US$235.00k | 0.0027% $ 85.4k |
6.8yrs
Gemiddelde duur
63yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van NEOG wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.8 jaar).